Zentalis Pharmaceuticals, Inc.
ZNTL • NASDAQ • Stock Fundamentals
Zentalis Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Julie Eastland, with a market cap of $281.9M.
Market Cap$281.9M
Employees168.0
CEOJulie Eastland
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026
View reportNext EarningsAug 5, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Zentalis Pharmaceuticals, Inc. FAQ
Common questions about Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. (ZNTL) has a market capitalization of $281.9M and trades on NASDAQ.
Zentalis Pharmaceuticals, Inc. has approximately 168 employees.